SCHEMBL28699696

SCHEMBL28699696

CC(C)(C)OC(=O)N(Nc1ccccc1)OC(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 6/20 0.42
PDK2 Q15119 6/20 0.42
PDK3 Q15120 6/20 0.42
PDK4 Q16654 6/20 0.42
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
AKT1 P31749 2/20 0.35
MLYCD O95822 1/20 0.35
HDAC3 O15379 2/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC2 Q92769 2/20 0.34
NCOR2 Q9Y618 1/20 0.34
ABCC9 O60706 2/20 0.34
ABCC8 Q09428 2/20 0.34
KCNJ11 Q14654 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28699987 0.83 KCNN4 (0.40) LMNACA12CA1CA7CA14
SCHEMBL29257492 0.81 PDK1 (0.41) PDK1PDK2PDK3PDK4LMNA
SCHEMBL28699685 0.76 AKT1 (0.38) PDK1PDK2PDK3PDK4CA12
SCHEMBL28715025 0.75 MAPT (0.38) LMNACA12CA1CA7CA14
SCHEMBL28708777 0.75 AKT1 (0.40) PDK1PDK2PDK3PDK4CA12
SCHEMBL4367466 0.71 GPR119 (0.40) L3MBTL1
SCHEMBL14697845 0.68 NFKB1 (0.40) LMNAAKT1HDAC3HDAC1HDAC2
SCHEMBL7659114 0.68 MTOR (0.50) PDK1PDK2PDK3PDK4MLYCD
SCHEMBL28699974 0.68 AKT1 (0.46) PDK1PDK2PDK3PDK4LMNA
SCHEMBL12311224 0.68 GBA1 (0.44) PDK2HDAC3HDAC1HDAC2NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114195676-B Biarylhydrazine compound and adduct thereof and application of compound in preparation of antitumor drugs 广州药本君安医药科技股份有限公司 2022-08-05 CN disclosed
CN-114195676-A Biarylhydrazine compound and adduct thereof and application of compound in preparation of antitumor drugs 广州药本君安医药科技股份有限公司 2022-03-18 CN disclosed